Molecular Epidemiology of Cancer
暂无分享,去创建一个
[1] J. Doorbar,et al. Human Papillomaviruses , 2006, Methods in Molecular Medicine.
[3] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[4] J. Dillner,et al. A population-based study of cervical carcinoma and HPV infection in Latvia. , 2004, Gynecologic oncology.
[5] N. Kiviat,et al. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. , 2004, American journal of epidemiology.
[6] Ash A. Alizadeh,et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.
[7] Stefano Bonassi,et al. Impact of Types of Lymphocyte Chromosomal Aberrations on Human Cancer Risk , 2004, Cancer Research.
[8] C. Sutter,et al. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue , 2004, Human mutation.
[9] Graham A Colditz,et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.
[10] H. Norppa. Cytogenetic biomarkers and genetic polymorphisms. , 2003, Toxicology letters.
[11] C. Harris,et al. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. , 2004, IARC scientific publications.
[12] L. Hagmar,et al. Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer. , 2004, IARC scientific publications.
[13] R. A. Hubbard,et al. Human papillomavirus testing methods. , 2009, Archives of pathology & laboratory medicine.
[14] Richard J Zarbo,et al. Human papillomavirus testing--are you ready for a new era in cervical cancer screening? , 2003, Archives of pathology & laboratory medicine.
[15] M. Ueda,et al. UV-induced skin damage. , 2003, Toxicology.
[16] F. X. Bosch,et al. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. , 2003, Journal of the National Cancer Institute. Monographs.
[17] H. Cubie. When is an STD not an STD? - HPV and Cervical Cancer , 2003 .
[18] L. Staudt. Molecular diagnosis of the hematologic cancers. , 2003, The New England journal of medicine.
[19] M. Schiffman,et al. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. , 2003, Journal of the National Cancer Institute.
[20] X. Wang,et al. TP53 and liver carcinogenesis , 2003, Human mutation.
[21] R. Weinshilboum. Inheritance and drug response. , 2003, The New England journal of medicine.
[22] K. Kulp,et al. Human exposure to heterocyclic amine food mutagens/carcinogens: Relevance to breast cancer , 2002, Environmental and molecular mutagenesis.
[23] M. Leppert,et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.
[24] B. Teh,et al. The management of familial breast cancer. , 2000, Breast.
[25] H. Adami,et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.
[26] J. Miller,et al. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. , 2000, Virology.
[27] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[28] M. Knize,et al. Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagens/carcinogens. , 1999, Advances in experimental medicine and biology.
[29] W C Willett,et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. , 1998, Cancer research.
[30] L. Aaltonen,et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.
[31] N. Dumaz,et al. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. , 1997, Carcinogenesis.
[32] R. Tarone,et al. Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Cerhan,et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[34] N. Dumaz,et al. The specificity of p53 mutation spectra in sunlight induced human cancers. , 1995, Journal of photochemistry and photobiology. B, Biology.
[35] F. X. Bosch,et al. Correspondence Re: M. Schiffman and A. Schatzkin, test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. (suppl.), 54: 1944s-1947s, 1994. , 1994, Cancer research.
[36] R. Fleischmann,et al. Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.
[37] M. Schiffman,et al. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. , 1994, Cancer research.
[38] D. English,et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] T. Jacks,et al. Sunburn and p53 in the onset of skin cancer , 1994, Nature.
[40] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[41] N. Copeland,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.
[42] Paul A. Schulte,et al. Molecular epidemiology : principles and practices , 1993 .
[43] C. Sutter,et al. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. , 1992, Cancer research.
[44] F. X. Bosch,et al. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer , 1992, Journal of clinical microbiology.
[45] J. Simon,et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Wands,et al. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.
[47] R. Metcalf,et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. , 1991, Nature.
[48] C. Wild,et al. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. , 1990, Cancer research.
[49] R. Kerr. Indoor radon: the deadliest pollutant. , 1988, Science.
[50] J. Bigby. Harrison's Principles of Internal Medicine , 1988 .
[51] J. Essigmann,et al. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats. , 1981, Cancer research.
[52] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[53] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.